454 Followers on Owler

Pictet AM

Read more
Laurent Ramsey's photo - CEO of Pictet AM

CEO

Laurent Ramsey

CEO Approval Rating

88/100

Founded:

1805

Status:

Investment CompanyIndependent Company

Est. Annual Revenue
$3.3B
Est. Employees
4,600
Sector

Update Industry

PICTET AM TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Pictet AM's company profile
Laurent Ramsey's photo - CEO of Pictet AM

Laurent Ramsey

CEO

88/100
4,600
$0
$3.3B
View Profile
1
Pictet AM's Competitor - Julius Baer logo
Philipp Rickenbacher's photo - CEO of Julius Baer

Philipp Rickenbacher

CEO

77/100
6,606
- -
$4.1B
View Profile
2
Pictet AM's Competitor - Lombard Odier logo
Patrick Odier's photo - Managing Partner of Lombard Odier

Patrick Odier

Managing Partner

82/100
2,432
- -
$1.6B
View Profile
3
Pictet AM's Competitor - UBS logo
Ralph Hamers's photo - CEO of UBS

Ralph Hamers

CEO

53/100
71,551
$6.6B
$34.7B
View Profile
4
Pictet AM's Competitor - Royal Bank of Scotland logo
Alison Rose's photo - CEO of Royal Bank of Scotland

Alison Rose

CEO

57/100
62,900
- -
$689.7M
View Profile
5
Pictet AM's Competitor - Deutsche Bank logo
Christian Sewing's photo - CEO of Deutsche Bank

Christian Sewing

CEO

56/100
83,797
- -
$31.3B
View Profile
6
Pictet AM's Competitor - Lazard logo
Kenneth M. Jacobs's photo - Chairman & CEO of Lazard

Kenneth M. Jacobs

Chairman & CEO

59/100
2,996
$4.1B
$3B
View Profile
7
Pictet AM's Competitor - Bank of America logo
Brian Moynihan's photo - Chairman & CEO of Bank of America

Brian Moynihan

Chairman & CEO

60/100
204,489
- -
$84.7B
View Profile
8
Pictet AM's Competitor - Raymond James logo
Paul C. Reilly's photo - Chairman & CEO of Raymond James

Paul C. Reilly

Chairman & CEO

66/100
14,200
- -
$9.2B
View Profile
9
Pictet AM's Competitor - Bank of Ireland logo
Francesca McDonagh's photo - CEO of Bank of Ireland

Francesca McDonagh

CEO

54/100
9,211
- -
$5.3B
View Profile
10
Pictet AM's Competitor - Citibank logo
Michael L Corbat's photo - CEO of Citibank

Michael L Corbat

CEO

77/100
158,759
- -
$33B
View Profile
11
Pictet AM's Competitor - JPMorgan Chase logo
Jamie Dimon's photo - Chairman & CEO of JPMorgan Chase

Jamie Dimon

Chairman & CEO

59/100
256,105
$1.7B
$120.9B
View Profile
12
Pictet AM's Competitor - Morgan Stanley logo
James P. Gorman's photo - Chairman & CEO of Morgan Stanley

James P. Gorman

Chairman & CEO

68/100
57,633
$24.3B
$55.2B
View Profile

Missing a competitor? Contribute!

Julius Baer is Pictet AM's top competitor. Julius Baer was founded in 1890 in Zurich, Zurich. Julius Baer competes in the Investment Banking & Brokerage field. Julius Baer generates $790.5M more revenue than Pictet AM.

Lombard Odier is perceived as one of Pictet AM's biggest rivals. Lombard Odier's headquarters is in Geneva, Geneva, and was founded in 1796. Lombard Odier is in the Asset & Investment Management industry. Lombard Odier generates 48% of Pictet AM's revenue.

UBS is one of Pictet AM's top competitors. UBS is a Public company that was founded in Zurich, Zurich in 1862. UBS operates in the Banks industry. UBS has 66,951 more employees vs. Pictet AM.

Pictet AM Acquisitions

No recent acquisitions found related to Pictet AM

Pictet AM Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Jun 2020
--
-
Investment Fund
Sep 2019
--
-

Since Pictet AM was founded in 1805, it has participated in 2 rounds of funding. In total Pictet AM has raised $0. Pictet AM's last funding round was on Jun 2020 for a total of $0

Pictet AM Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Chainalysis is a New York-based blockchain analysis company that provides crypto-risk management and compliance solutions for financial institutions and government agencies.
$100M
Jun 23, 2021
-
NovImmune discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer.
$29.8M
Jan 10, 2016
-
NovImmune discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer.
$54.8M
May 11, 2009
-
NovImmune discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer.
$46M
Oct 29, 2006
-
ChemoCentryx is a biopharmaceutical company that focuses on discovering and developing orally-administered therapeutics to treat autoimmune diseases.
$33M
Jun 16, 2004
-

These are all the companies that Pictet AM has invested in. Pictet AM has invested 5 companies and its latest investment was Chainalysis in Jun 23,. Chainalysis is a New York-based blockchain analysis company that provides crypto-risk management and compliance solutions for financial institutions and government agencies.

Pictet AM News

December 1, 2020IFA Magazine

Pictet Asset Management launch Human, a new thematic fund

Pictet Asset Management (Pictet AM) has announced the launch of Pictet-Human, a new fund within its U... See more »
November 23, 2020MarketScreener

Swiss group Pictet opens Shanghai unit to tap China's fund market

(marketscreener.com) Geneva-based Pictet Group's asset management arm announced the opening of its Sh... See more »
November 23, 2020Finews Asia

Pictet Asset Management Opens Wholly-Owned Unit in Shanghai

Pictet's asset management arm joins the wave of foreign fund houses seeking to capitalize on China's ... See more »
October 8, 2020Investmentweek

Pictet AM adds higher risk/return fund to total return range

Pictet Asset Management has launched a higher risk, higher return version of its existing Pictet TR-A... See more »
October 7, 2020Global Sage

Pictet Asset Management has named Elizabeth Dillon its new U.S. Chief Executive Officer.

Pictet Asset Management has named Elizabeth Dillon its new U.S. Chief Executive Officer. Previously, ... See more »

Pictet AM Press Releases

Pictet AM Videos

Social Media

Pictet AM Headquarters

Route des Acacias 60

Geneva, Geneva1211

4158-323-3333

Driving Directions »

Trending Companies

Pictet AM Summary

ABOUT

Overview

Pictet AM is a provider of asset management services for institutional investors and financial intermediaries. Pictet AM was founded in 1805. Pictet AM's headquarters is located in Geneva, Geneva, CH 1211. Pictet AM's CEO, Laurent Ramsey, currently h...

CEO

Pictet AM's CEO, Laurent Ramsey, currently has an approval rating of 88%. Pictet AM's primary competitors are Julius Baer, Lombard Odier & UBS.

Website

am.pictet

Frequently Asked Questions about Pictet AM

  1. When was Pictet AM founded?

    Pictet AM was founded in 1805
  2. Who is Pictet AM's CEO?

    Pictet AM's CEO is Laurent Ramsey
  3. How much revenue does Pictet AM generate?

    Pictet AM generates $3.3B in revenue
  4. How much funding does Pictet AM have?

    Pictet AM has historically raised $0 in funding
  1. Where is Pictet AM's headquarters?

    Pictet AM's headquarters is in Geneva Geneva, CH
  2. How many employees does Pictet AM have?

    Pictet AM has 4,600 employees
  3. Who are Pictet AM's competitors?

    Pictet AM's top competitors are Julius Baer, Lombard Odier, UBS
  4. Who has Pictet AM invested in?

    Pictet AM's has invested in companies such as Chainalysis, NovImmune, NovImmune